বাংলায় দেখুন
Loracef

Loracef

Powder for Suspension

🧬 Cefaclor Monohydrate 🏢 Square Pharmaceuticals PLC
Generic Name Cefaclor Monohydrate
Manufacturer Square Pharmaceuticals PLC
Unit Price 100 ml bottle: ৳ 201.00

🔹 Indications

Loracef is indicated for the treatment of the following infections:
  • Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes
  • Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
  • Pharyngitis and Tonsillitis, caused by Streptococcus pyogenes
  • Urinary tract infections, including pyelonephritis and cystitis, caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative Staphylococci
  • Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.

🔹 Pharmacology

Loracef is indicated for the treatment of the following infections:
  • Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes
  • Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
  • Pharyngitis and Tonsillitis, caused by Streptococcus pyogenes
  • Urinary tract infections, including pyelonephritis and cystitis, caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative Staphylococci
  • Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.

🔹 Dosage & Administration

Loracef is indicated for the treatment of the following infections:
  • Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes
  • Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
  • Pharyngitis and Tonsillitis, caused by Streptococcus pyogenes
  • Urinary tract infections, including pyelonephritis and cystitis, caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative Staphylococci
  • Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.

🔹 Interaction

Loracef is indicated for the treatment of the following infections:
  • Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes
  • Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
  • Pharyngitis and Tonsillitis, caused by Streptococcus pyogenes
  • Urinary tract infections, including pyelonephritis and cystitis, caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative Staphylococci
  • Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.

🔹 Contraindications

Loracef is indicated for the treatment of the following infections:
  • Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes
  • Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
  • Pharyngitis and Tonsillitis, caused by Streptococcus pyogenes
  • Urinary tract infections, including pyelonephritis and cystitis, caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative Staphylococci
  • Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.

🔹 Side Effects

Loracef is indicated for the treatment of the following infections:
  • Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes
  • Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
  • Pharyngitis and Tonsillitis, caused by Streptococcus pyogenes
  • Urinary tract infections, including pyelonephritis and cystitis, caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative Staphylococci
  • Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.

🔹 Pregnancy & Lactation

Loracef is indicated for the treatment of the following infections:
  • Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes
  • Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
  • Pharyngitis and Tonsillitis, caused by Streptococcus pyogenes
  • Urinary tract infections, including pyelonephritis and cystitis, caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative Staphylococci
  • Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.

🔹 Precautions & Warnings

Loracef is indicated for the treatment of the following infections:
  • Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes
  • Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
  • Pharyngitis and Tonsillitis, caused by Streptococcus pyogenes
  • Urinary tract infections, including pyelonephritis and cystitis, caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative Staphylococci
  • Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.

💡 Frequently Asked Questions

Loracef is indicated for the treatment of the following infections: Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes Otitis media caused by Streptoc...
Loracef is indicated for the treatment of the following infections: Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes Otitis media caused by Streptoc...
Loracef is indicated for the treatment of the following infections: Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes Otitis media caused by Streptoc...

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review